Envoy Medical (NASDAQ:COCH – Get Free Report) and Inogen (NASDAQ:INGN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
Profitability
This table compares Envoy Medical and Inogen’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Envoy Medical | N/A | N/A | -100.39% |
Inogen | -32.46% | -38.98% | -27.03% |
Institutional & Insider Ownership
8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 0.7% of Envoy Medical shares are held by insiders. Comparatively, 0.6% of Inogen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Risk and Volatility
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Envoy Medical and Inogen, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Envoy Medical | 0 | 0 | 2 | 0 | 3.00 |
Inogen | 1 | 2 | 1 | 0 | 2.00 |
Envoy Medical currently has a consensus price target of $6.00, suggesting a potential upside of 15.83%. Inogen has a consensus price target of $7.50, suggesting a potential upside of 10.62%. Given Envoy Medical’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Envoy Medical is more favorable than Inogen.
Earnings & Valuation
This table compares Envoy Medical and Inogen’s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Envoy Medical | $320,000.00 | 317.28 | -$29.91 million | N/A | N/A |
Inogen | $315.66 million | 0.51 | -$102.45 million | ($4.41) | -1.54 |
Envoy Medical has higher earnings, but lower revenue than Inogen.
Summary
Envoy Medical beats Inogen on 9 of the 12 factors compared between the two stocks.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.